VRM: Gardasil/Cervarix – A Legacy Of Shame

Vaccine Resistant Movement

by Joel Lord

20th February 2011 – By Joel Lord

The headlines alone tell the whole story. ‘Teenage girl left brain-damaged after receiving cervical cancer jab‘, ‘Thousands of UK schoolgirls have suffered adverse reactions…several reported multiple reactions’, ‘20,575 adverse reactions, 352 reports of abnormal pap smears post vaccination, 89 reported deaths’, ‘New Worries About Gardasil Safety’, ‘Cervical Cancer Vaccine May Raise Risk of Guillain-Barre Syndrome’, ‘8 more deaths connected to HPV vaccine’…

Merck Funded Study States – Gardasil Equally Effective for Males and Females

SANE Vax, Inc. is Concerned about Missing Data in the Reports
FOR IMMEDIATE RELEASE

PRLog (Press Release) – Feb 21, 2011 – The media went wild last week announcing the report published in the Feb. 3 issue of the New England Journal of Medicine, (NEJM) was funded by the vaccine’s maker, Merck & Co., 1 stating Gardasil was 90 percent effective in older teenaged boys and young men.

Sick Brains in Teens – Is There A Root Cause?

Natural News

Thursday, February 03, 2011 by: Dr Sherri Tenpenny

It’s been nearly a month since the nation’s attention was focused on Tucson, where five were killed and 13 injured , including Congresswoman Gabrielle Giffords, several other shootings missed the mainstream news. Violence seems to be erupting among youths everywhere, from Los Angeles(1) to Omaha(2) to Brooklyn(3) – indicating something is seriously going wrong in the minds of young persons in this country.

Faulty testosterone cycle may explain male autism bias

New Scientist
15:04 17 February 2011 by Ferris Jabr

More men than women have autism – now we may know why. Sex hormones regulate a gene linked with the condition, making it more likely that males will accumulate testosterone in the dangerous amounts that are thought to lead to autism.

Dangerous Gardasil Vaccine Could Become Mandatory

New American

Written by Kelly Holt
Tuesday, 08 February 2011 13:00

Even as stories continue to surface about young girls who have suffered a host of side effects, including death, after taking the Gardasil vaccine, the drug still has not been tested for or proven as cancer-preventing. And now ObamaCare is calling for mandatory vaccinations and proof of updates in order to get healthcare.The vaccine is promoted as a protection against various types of cancer thought to be caused by the HPV virus, but none of the active ingredients have been approved under the Food, Drug, and Cosmetic Act, the Public Health Service Act, or the Virus-Serum-Toxin Act, according to their application for patent, reported the PPJ Gazette for Feb. 6, 2011.

Expert says boys must be offered cancer jab

The Sydney Morning Herald
Amy Corderoy HEALTH
February 8, 2011

THE immunisation program that protects girls against the virus linked to cervical cancer should immediately be extended to boys to prevent other cancers, a leading epidemiologist says.

HPV vaccine effective in men

CNN News
By Lynne Peeples, Health.com
February 3, 2011 6:11 a.m. EST

(Health.com) — Boys and young men who receive the human papillomavirus vaccine appear to be at reduced risk of contracting the virus and developing the genital warts associated with the common sexually transmitted disease, according to a large international study published this week in the New England Journal of Medicine.

New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL® in Males

Business Wire
Merck
February 02, 2011 05:09 PM Eastern Time

WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (known as MSD outside the United States and Canada) announced today that data from the pivotal Phase III study with GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] in males were published in the February 3 issue of the New England Journal of Medicine (NEJM).

New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL® in Males

Business Wire

February 2, 2011

WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (known as MSD outside the United States and Canada) announced today that data from the pivotal Phase III study with GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] in males were published in the February 3 issue of the New England Journal of Medicine (NEJM). In this study, GARDASIL was 89 percent effective against human papillomavirus (HPV) types 6- and 11- related genital warts in males aged 16 through 26. This Phase III study is the only study to demonstrate the efficacy of an HPV vaccine in males, and provided data that supported the U.S. Food and Drug Administration (FDA) approval of GARDASIL in October 2009 for the prevention of genital warts caused by HPV types 6 and 11 in boys and men ages 9 to 26 years.

Men more accepting of HPV vaccine when considering cancer reduction

VIHV Vaccine Injury Help Center

by RachelB.
Law Offices of Sadaka Associates on January 11, 2011

For several years, the cervical cancer vaccine Gardasil, and its European cousin Cervarix has been on the market with mixed reviews, to say the least. Just as Indian health officials announced the cessation of trials surrounding the drug in their country due to the deaths of six young girls, other health care representatives are looking for ways to promote its use. Gardasil, which is manufactured by Merck laboratories has been linked to a variety of autoimmune dysfunctions including Guillain Barre Syndrome, Lou Gehrig’s Disease, hair loss, coma, seizures and even death. Some claim that government vaccination monitoring systems and the manufacturer are working over time to cover up complications, all while media hype plays up the benefits of a potentially deadly drug.